Endo‐epicardial ablation vs endocardial ablation for the management of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta‐analysis.

Background: The pathologic process of ARVC (arrhythmogenic right ventricular cardiomyopathy) typically originates in the epicardium or subepicardial layers with progression toward endocardium. However, in the most recent ARVC international task force consensus statement, epicardial ventricular tachy...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Cardiovascular Electrophysiology Vol. 31; no. 8; pp. 2022 - 2032
Autores principales: Romero, Jorge, Patel, Kavisha, Briceno, David, Alviz, Isabella, Gabr, Mohamed, Diaz, Juan Carlos, Trivedi, Chintan, Mohanty, Sanghamitra, Della Rocca, Domenico, Al‐Ahmad, Amin, Yang, Ruike, Rios, Saul, Cerna, Luis, Du, Xianfeng, Tarantino, Nicola, Zhang, Xiao‐Dong, Lakkireddy, Dhanunjaya, Natale, Andrea, Di Biase, Luigi
Formato: meta analysis research systematic review tables/charts Journal Article
Publicado: Wiley-Blackwell Aug2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=144883791&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 144883791
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10453873
        GSB
      jtl: Journal of Cardiovascular Electrophysiology
      issn: 10453873
      maglogo: Y
    pubinfo:
      dt: Aug2020
      vid: 31
      iid: 8
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        144883791
        144883791
        145769972
        144883791
        10.1111/jce.14593
        144883791
      ppf: 2022
      ppct: 10
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: C
          – @attributes:
              type: P
      tig:
        atl: Endo‐epicardial ablation vs endocardial ablation for the management of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta‐analysis.
      aug:
        au:
          Romero, Jorge
          Patel, Kavisha
          Briceno, David
          Alviz, Isabella
          Gabr, Mohamed
          Diaz, Juan Carlos
          Trivedi, Chintan
          Mohanty, Sanghamitra
          Della Rocca, Domenico
          Al‐Ahmad, Amin
          Yang, Ruike
          Rios, Saul
          Cerna, Luis
          Du, Xianfeng
          Tarantino, Nicola
          Zhang, Xiao‐Dong
          Lakkireddy, Dhanunjaya
          Natale, Andrea
          Di Biase, Luigi
        affil: Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx New York
      sug:
        subj:
          Tachycardia, Ventricular Therapy
          Myocardial Diseases Therapy
          Heart Ventricle, Right Pathology
          Catheter Ablation Methods
          Human
          Systematic Review
          Meta Analysis
          PubMed
          Embase
          Cochrane Library
          Treatment Outcomes
      ab: Background: The pathologic process of ARVC (arrhythmogenic right ventricular cardiomyopathy) typically originates in the epicardium or subepicardial layers with progression toward endocardium. However, in the most recent ARVC international task force consensus statement, epicardial ventricular tachycardia (VT) ablation is recommended as a Class I indication only in patients with at least one failed endocardial VT ablation attempt. Objective: The aim of this meta‐analysis is to assess the outcomes of ARVC patients undergoing combined endo‐epicardial VT ablation, as compared to endocardial ablation alone. Methods: A systematic review of PubMed, Embase, and Cochrane was performed for studies reporting clinical outcomes of endo‐epicardial VT ablation vs endocardial‐only VT ablation in patients with ARVC. Fixed‐Effect model was used if I2 < 25 and the Random‐Effects Model was used if I2 ≥ 25%. Results: Nine studies consisting of 452 patients were included (mean age 42.3 ± 5.7 years; 70% male). After a mean follow‐up of 48.1 ± 21.5 months, endo‐epicardial ablation was associated with 42% relative risk reduction in VA recurrence as opposed to endocardial ablation alone (risk ratio [RR], 0.58; 95% confidence interval [CI], 0.45‐0.75; P <.0001). No significant differences were noted between endo‐epicardial and endocardial VT ablation groups in terms of all‐cause mortality (RR, 1.19; 95% CI, 0.03‐47.08; P =.93) and acute procedural complications (RR, 5.39; 95% CI, 0.60‐48.74; P =.13). Conclusions: Our findings suggest that in patients with ARVC, endo‐epicardial VT ablation is associated with a significant reduction in VA recurrence as opposed to endocardial ablation alone, without a significant difference in all‐cause mortality or acute procedural complications.
      pubtype: Academic Journal
      doctype:
        meta analysis
        research
        systematic review
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N